EB
Evaxion Biotech AS
🇺🇸XNAS.EVAXUnited StatesHealthcare
$3.08USDup +0.01 (+0.33%)ClosedEnd of day8:30 PM
Price$3.08+0.01 (+0.33%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US29970R3030
- CUSIP
- 29970R105
Company
- Employees
- 46
- Headquarters
- Horsholm, United States
- Website
- https://evaxion.ai
- CEO
- Dr. Helen Katrina Tayton-Martin MBA, Ph.D.
Market
- Shares outstanding
- 9M
- Market cap
- $27.79M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
No high and low reported for today's session.
- Market cap
- $27.79M
- EPS LTM
- -$20.75
- P/E LTM
- -0.15
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $7.51M+127.84%up year on year
- Net income
- -$8.65M+27.74%up year on year
- Gross margin
- -0.49%
- Free cash flow
- -$6.66M
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.